Since most adults with prediabetes and type 2 diabetes are people with overweight or obesity, access to the full continuum of care to treat obesity is another important tool to reduce new cases of type 2 diabetes and to help adults with diabetes sustain weight loss in the longer term.

The COVID-19 pandemic has demonstrated and reinforced the urgent need to address diabetes and obesity, as these two conditions have been shown to be major risk factors for hospitalizations and death from COVID-19. It has also demonstrated that different modalities can be effective in delivering therapy and treating medical conditions.

The DAA provides information and education to members of Congress and the Administration about the obesity/diabetes connection, and some DAA members support coverage of the full continuum of care to treat obesity, as described in the Treat and Reduce Obesity Act of 2021 (S. 596; H.R. 1577).